Absolutely how I see it..Big Pharma and Trials in the mix requires investment in MYDX period. not a lot of companies do a seperate site but there may be worries of overload on the servers once it takes off and lessen the confusion on the product site as to what is what. Makes total sense to me. A whale portfolio of info on the company. With downloadable magazine in pdf
"PROVIDING INFORMATION AND RESEARCH TO CANNABIS INVESTORS" Special Edition 2017
============================================
Don't forget what if there is a licensing deal in the works to combine Lexaria products into these formulas to make them the most potent targeted CBD formulas on the market today? What about that! Boom!
They were rubbing elbows in the last video right?
Lexaria Bioscience Corp’s disruptive new technology DehydraTECH™ is available to be licensed.
DehydraTECH™ can be used to improve existing products or to create new products. It is suitable for use with a wide range of consumer product formats including:
Investors welcomed at $MYDX is what it says to me. Simple transparency to all products or investment find it here..
Once we confirm our findings via formal clinical trials, we can use, sell or license those formulations to develop bio-pharmaceuticals and other consumer products.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is. Do Your Own DD Do not take my investing advice.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.